2008 U.S. Diabetes Drug Delivery - Physician Perspective


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This study encompasses feedback provided by U.S. physicians who treat diabetes on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current and future trends. Analysis includes issues such as awareness, usage, preferences, influencing criteria, patient compliance, desired delivery types to be made available, as well as feedback on the role the device plays in the prescribing decision for a drug. The corresponding patient deliverable is titled: 2008 U.S. Diabetes Drug Delivery: Patient Perspective (N7C0).

Table of Contents

2008 U.S. Diabetes Drug Delivery - Physician Perspective, 2008 U.S. Diabetes Drug Delivery - Physician PerspectiveIntroductionTitleDisclaimerCertificationTable of ContentsList of ChartsResearch Background - Objectives - Method Details - Demographic ProfileResearch BackgroundMethod DetailsScopeDemographic Profile of RespondentsExecutive SummaryExecutive SummaryOverview of Awareness - Usage - PreferencesGeneral Awareness of Drug Delivery MethodsDiabetes Drug Availability OverviewShare of Prescription / UsageFrequency of Usage of Drug Delivery MethodSatisfaction with Diabetes Drug Delivery MethodsPreferred Delivery MethodReasons for Preference of Drug Delivery MethodCurrently Unavailable but Desirable Drug Delivery MethodsReasons for Drug Delivery Method to be Made AvailableDoctor' Perception of Patients' PreferencesPerceived Reasons for Patient's Choice PreferenceClass of Drug Prescribed for Total DiabetesPreferred Drug Delivery Method by Drug Class if All Types AvailableDrug Delivery Method - Trends for Next 12-24 Months (2008-2009)General Criteria and Perceptions that Influence Drug Delivery Type PreferenceFactors for Selecting Drug Delivery TypePerceived Association of Delivery Types with Various AttributesAttitude towards New Delivery FormsImportance of Overall Device in Final Selection to PrescribeFactors for Selecting Device Driven DrugsProfile of Patient Compliance and Administering PersonsPatient's Adherence to Therapy by Drug Delivery MethodFactors Impacting Patient CompliancePerson who Administers the MedicationAbout Frost & SullivanFrost & Sullivan

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.